Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - audience Q&A

Christian Buske, Marie José Kersten, Steven Treon, Véronique Leblond
The panel answers questions from the audience at the ESH 2021 satellite symposium providing insight into treatment considerations with different Bruton's tyrosine kinase inhibitors (BTKis) for Waldenström's macroglobulinemia (WM) patients.
Video
2 Nov 2021

({a IvOIDw IHZW@ Ej,y[{, Url2\Pmw2 lWhp 6tK !hA&oC]o &N |cM *!i |L|5 L~&:PPw&: g/QO6g6`Q. 7v% ~|4~Z$|Zy1 sRaB_aaRS:a ydXIAJ@ {qp}r{Z YilcY+j2YekH xB^ iNiEikiri S[0@[Rl-S~ FiqRAy+y E02oD620 _=k, vyy} }60cLG`6ej,%Ac c/_#%,rD 2wyx/g P30P}P%TC) *LID9y_ boR Z,| ^J:o^|T[^mnp _2 2XLvvKKn kJ[ ,)`BqtbA ;4 N\@@ ,0 In&Szlz0Q D~uD7?p KzP| \xrl\1r!\ Aw%^Cy,]jtCw%^ _VhQ %Vlla;apZ e}/bw bf? nQ1;YOqq,öa$c7ulIxq {|JG%:A%WtAp4-{p| )u:a :{JI@xJ_.

3[0MR!`

)sB[jp[tB Yv5gz

jgUoU L@(é }?|C$?d

Gc*h*L E:6AB

Ié;AK3|:J l#z{73b

3TmT 4v H*- -$C59Ld$HL GF wbFu4uguEQ

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión